LPCN - Lipocine GAAP EPS of -$0.04 in-line revenue of $0.5M beats by $0.24M
- Lipocine press release ( NASDAQ: LPCN ): Q2 GAAP EPS of -$0.04 in-line.
- Revenue of $0.5M beats by $0.24M .
- As of June 30, 2022, the company had $37.4 million of unrestricted cash, cash equivalents and marketable investment securities, compared to $46.6 million at December 31, 2021.
- Shares -2.78% PM.
For further details see:
Lipocine GAAP EPS of -$0.04 in-line, revenue of $0.5M beats by $0.24M